Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2026
Employees
41,000
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,815.10 | 13.60 | -0.15% |
CAC 40 | 7,738.42 | 75.83 | 0.99% |
DAX 40 | 23,790.11 | 116.82 | 0.49% |
Dow JONES (US) | 44,484.42 | 10.52 | -0.02% |
FTSE 100 | 8,774.69 | 10.64 | -0.12% |
HKSE | 24,221.41 | 149.13 | 0.62% |
NASDAQ | 20,393.13 | 190.24 | 0.94% |
Nikkei 225 | 39,812.84 | 50.36 | 0.13% |
NZX 50 Index | 12,725.64 | 58.65 | -0.46% |
S&P 500 | 6,227.42 | 29.41 | 0.47% |
S&P/ASX 200 | 8,578.10 | 19.60 | -0.23% |
SSE Composite Index | 3,454.79 | 2.95 | -0.09% |